Although few side effects have been shown but never heard about headaches or migraine, Ligandrol is more suppressive of endogenous testosterone and sex hormone-binding globulin than other SARMs, making a full post-cycle therapy necessary. Ligandrol has not shown effects on luteinizing hormone, follicle stimulating hormone, or estradiol too.